Abstract
Effect of RIPK1 Inhibitor, SAR443820, on Serum Neurofilament Light Levels in Patients with Multiple Sclerosis: A Phase 2 Trial Design (P6-3.011)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have